Skip to Main Content

Mina Xu, MD

Professor of Pathology
DownloadHi-Res Photo

Additional Titles

Director of Hematopathology, Pathology

Director, Expert Consultation Practice, Pathology

About

Titles

Professor of Pathology

Director of Hematopathology, Pathology; Director, Expert Consultation Practice, Pathology

Appointments

Education & Training

Fellowship
Brigham & Women's Hospital (2011)
Residency
Yale-New Haven Hospital (2010)
MD
University of California at San Francisco (2006)
BA
Harvard University, Biology (2000)

Research

Overview

Medical Subject Headings (MeSH)

Biomarkers, Tumor; Bone Marrow; Leukemia; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes

Research at a Glance

Yale Co-Authors

Frequent collaborators of Mina Xu's published research.

Publications

Featured Publications

2024

Academic Achievements & Community Involvement

  • honor

    American Society of Hematology Trainee Grant

  • honor

    Weizmann Institute of Science Scholarship

  • honor

    Westinghouse Science Award

  • honor

    National Science Foundation Trainee Grant

Clinical Care

Overview

Mina Xu, MD, is a pathologist who specializes in diagnosing blood diseases and blood cancers—also called hematopathology. Her clinical practice focuses on giving the most accurate diagnosis and prognosis on tumors such as lymphoma, leukemia, and myeloma. At Yale School of Medicine, Dr. Xu is the director of hematopathology and is an associate professor in the departments of pathology and of laboratory medicine. Her academic mission is to study the pathogenesis of human hematopoietic malignancies and translate these findings into diagnostic and therapeutic advances in the field.

“Our role as pathologists includes running specialty tests on patient samples, such as protein analysis or molecular genetic testing, and most importantly, interpreting microscopic images of tissue samples,” Dr. Xu says, adding that she occasionally speaks directly to patients who are interested in learning more about their diseases. “Because we make such critical decisions that guide treatment, we should not be separated from patient care.”

Dr. Xu believes a single biopsy can be thought of as a piece of a larger story. “When you see a tumor evolving from different biopsies, you can put that part of the story into a larger narrative and help patients understand how the disease is changing,” says Dr. Xu. “Some of the success stories in my field center around finding ways to tailor our treatment to the specific genetic abnormality of an otherwise fatal cancer and make it a chronic or curable condition.”

Clinical Specialties

Pathology; Anatomic Pathology; Hematopathology

Fact Sheets

Board Certifications

  • Anatomic & Clinical Pathology

    Certification Organization
    AB of Pathology
    Original Certification Date
    2010

Get In Touch

Contacts

Academic Office Number
Clinical Inquiry Number
Office Fax Number

Administrative Support

Locations

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.